Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arar Capital is a São Paulo-based venture capital firm that specializes in sustainable agribusiness and biotechnology, focusing on the "knowledge-based bioeconomy." The firm primarily invests in early-stage startups that leverage advanced science—such as genome editing, microbiome analysis, and artificial intelligence—to enhance agricultural productivity and environmental sustainability. Arar Capital's portfolio includes notable biotechnology and agtech companies like Symbiomics, which focuses on high-performance biologicals, and Produzindo Certo, a platform for environmental compliance. By providing strategic capital to the agtech and AgBiotech sectors, the firm aims to catalyze the transition to a more resilient and sustainable global food system. The company is a key player in the Brazilian innovation ecosystem, often co-investing with global agriculture leaders like Corteva.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arar Capital.